Could The GIT1 Protein Be Used to Inhibit Breast Cancer Growth?
A recent study at Sweden’s Karolinska Institute has revealed that a protein called GIT1 has shown the ability to protect against the growth of estrogen receptor-negative breast tumors. This type of breast cancer is among the most difficult variations to treat, and the...
Could This Immunotherapy Drug Improve Head and Neck Cancer Outcomes?
A clinical trial at the University of Cincinnati has found that adding a newly developed immunotherapy drug to standard treatment methods could improve survival rates for head and neck cancer patients. The trial was led by Trisha Wise-Draper, MD, and published in the...
Colorectal Cancer Study Continues with $10 Million in New Funds
An international study researching innovations in the treatment of colorectal cancer was bolstered in early February by a five-year renewal and $10 million in new funding. Based at the Huntsman Cancer Institute at the University of Utah, the ColoCare Study commenced...
These 2 Stem Cell Discoveries by Cedars-Sinai Scientists Could Improve Cancer Treatment
A team of stem cell scientists from Cedars-Sinai Medical Center in Los Angeles recently made two discoveries that could have major implications for cancer treatment. Researchers in the first study made a discovery that could drastically improve the efficiency of...
How Machine Learning Could be Used to Improve Cervical Cancer Outcomes
A variety of technological innovations have made modern-day cancer research exciting, as findings of various studies have provided hope for next-generation treatment methods that could save countless lives. Machine learning methods of data analysis are one of many...
Newly Approved Drug Cytalux Could Increase Ovarian Cancer Survival Rates
In November 2021, a cancer treatment agent called Cytalux was approved by the US Food and Drug Administration (FDA). Between 22,000 and 24,000 women are diagnosed with ovarian cancer each year in the United States. Oncologists are hopeful that this new treatment can...
Could This MUSC Study Improve Colorectal Cancer Treatment and Prevention?
Colorectal cancer is one of the most common forms of cancer and, as the second-leading cause of cancer deaths, it is also one of the most serious. For years, cancer researchers have been searching for ways to prevent and treat colorectal cancer more...
How Purdue University’s New Mutation-Based Cancer Immunotherapy Could Help Patients
A potential cancer immunotherapy treatment has been developed by researchers at Purdue University’s College of Pharmacy. Led by Zhong-Yin Zhang, the researchers are continuing to develop the immunotherapy treatment, which is based on an enzyme mutation. The team of...
What the Growth of Asana Could Mean For the Future of Project Management Software
Project management company Asana went public in September 2020, and despite some volatility, its value has risen significantly since then. This San Francisco-based tech newcomer’s market arrival was highly anticipated in the industry, and as it continues to grow, it...
4 Emerging Brain Cancer Treatment Innovations Provide Hope For the Future
Cancer has affected the lives of the majority of Americans. According to a CBS News poll, 54% of Americans have either been diagnosed with cancer themselves, or have a family member who has been diagnosed. Brain cancer is the most common type of cancer among children...
